BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 24973048)

  • 1. A cross-sectional national questionnaire survey assessing the clinical attitudes of members of the British Menopause Society to the management of women with premature ovarian insufficiency.
    Mittal M; Savvas M; Narvekar N; Panay N; Hamoda H
    Post Reprod Health; 2014 Sep; 20(3):90-7. PubMed ID: 24973048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility desires, choice of hormone replacement and the effect of length of time since menopause on bone density in women with premature ovarian insufficiency: a review of 223 consecutive new referrals to a tertiary centre.
    Mittal M; Kreatsa M; Narvekar N; Savvas M; Hamoda H
    Post Reprod Health; 2014 Sep; 20(3):104-11. PubMed ID: 24973049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge and attitudes of health professionals regarding menopausal hormone therapies.
    Yeganeh L; Boyle J; Teede H; Vincent A
    Climacteric; 2017 Aug; 20(4):348-355. PubMed ID: 28379046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency.
    Hamoda H;
    Post Reprod Health; 2017 Mar; 23(1):22-35. PubMed ID: 28381102
    [No Abstract]   [Full Text] [Related]  

  • 5. Early menopause: primary ovarian insufficiency and surgical menopause.
    Kodaman PH
    Semin Reprod Med; 2010 Sep; 28(5):360-9. PubMed ID: 20845236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitude and knowledge for menopause management among health professionals in mainland China.
    Lin L; Feng P; Yu Q
    Climacteric; 2020 Dec; 23(6):614-621. PubMed ID: 32543223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional national questionnaire survey assessing the views of members of the British Menopause Society on the management of patients with unscheduled bleeding on hormone replacement therapy.
    Abdullahi Idle S; Panay N; Hamoda H
    Post Reprod Health; 2021 Sep; 27(3):159-165. PubMed ID: 34192961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms, health behavior and understanding of menopause therapy in women with premature menopause.
    Gibson-Helm M; Teede H; Vincent A
    Climacteric; 2014 Dec; 17(6):666-73. PubMed ID: 24742007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.
    Sullivan SD; Sarrel PM; Nelson LM
    Fertil Steril; 2016 Dec; 106(7):1588-1599. PubMed ID: 27912889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone therapy regimens for managing the menopause and premature ovarian insufficiency.
    Armeni E; Paschou SA; Goulis DG; Lambrinoudaki I
    Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101561. PubMed ID: 34274232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause.
    Kaplan B; Aschkenazi-Steinberg S; Yogev Y; Nahum R; Sulkes J; Phisher M
    Menopause; 2002; 9(5):354-9. PubMed ID: 12218724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy menopause with a better future--a survey of views on hormone replacement therapy (HRT).
    Shafi S; Samad Z; Syed S; Sharif A; Khan MA; Nehal US; Siddiqui AR
    J Pak Med Assoc; 2001 Dec; 51(12):450-3. PubMed ID: 11850984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: a randomised pilot trial.
    Mittal M; McEniery C; Supramaniam PR; Cardozo L; Savvas M; Panay N; Hamoda H
    Maturitas; 2022 Jul; 161():18-26. PubMed ID: 35688490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy for postmenopausal women with diabetes.
    Palin SL; Kumar S; Sturdee DW; Barnett AH
    Diabetes Obes Metab; 2001 Jun; 3(3):187-93. PubMed ID: 11412283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential prescribing of tibolone and combined estrogen plus progestogen therapy in postmenopausal women.
    Velthuis-Te Wierik EJ; Hendricks PT; Martinez C
    Menopause; 2007; 14(3 Pt 1):518-27. PubMed ID: 17224856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term health consequences of premature or early menopause and considerations for management.
    Faubion SS; Kuhle CL; Shuster LT; Rocca WA
    Climacteric; 2015; 18(4):483-91. PubMed ID: 25845383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should HRT be duration limited?
    Pitkin J
    Menopause Int; 2013 Dec; 19(4):167-74. PubMed ID: 24336246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature ovarian insufficiency: why is it not being diagnosed enough in primary care?
    Newson LR; Lewis R
    Br J Gen Pract; 2018 Feb; 68(667):83. PubMed ID: 29371305
    [No Abstract]   [Full Text] [Related]  

  • 19. A survey of views on hormone replacement therapy.
    Norman SG; Studd JW
    Br J Obstet Gynaecol; 1994 Oct; 101(10):879-87. PubMed ID: 7999690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy.
    Taylor HS; Kagan R; Altomare CJ; Cort S; Bushmakin AG; Abraham L
    Menopause; 2017 Jan; 24(1):27-34. PubMed ID: 27575548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.